| Megan Patricia Beemer, CNM | |
|
9100 W 74th St, Merriam, KS 66204-4004 | |
| (913) 676-2433 | |
| (913) 789-6700 |
| Full Name | Megan Patricia Beemer |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 9100 W 74th St, Merriam, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326703281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WM0102X | Registered Nurse - Maternal Newborn | 13-135842-071 (Kansas) | Secondary |
| 367A00000X | Advanced Practice Midwife | 53-80705 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Patricia Beemer, CNM 9100 W 74th St, Merriam, KS 66204-4004 Ph: (913) 676-2433 | Megan Patricia Beemer, CNM 9100 W 74th St, Merriam, KS 66204-4004 Ph: (913) 676-2433 |
News Archive
Mice with vision enhanced by nanotechnology were able to see infrared light as well as visible light, reports a study published February 28 in the journal Cell.
Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments.
Many physicians are pushing back against or debating new requirements for maintaining medical board certifications, which affect more than 250,000 physicians nationwide. Now, a new study by UC San Francisco and Stanford University researchers concludes that the cost of implementing the most recent requirements will be an estimated $5.7 billion over the next 10 years.
While Sen. Orrin Hatch, R-Utah, the Senate Finance Committee's ranking Republican, is taking an increasingly hard line on efforts to undo the health law, supporters of former Mass. Gov. Mitt Romney are giving him political cover as other GOP presidential hopefuls step up their attacks on "RomneyCare." Also, Politico reports that the health law continues to be a boon for the K Street economy.
GVK Biosciences, Asia's leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India.
› Verified 9 days ago